In a major advancement for regenerative medicine and medical 3D printing, the U.S. Food and Drug Administration (FDA) has granted de novo approval for a new bioresorbable implant designed for peripheral nerve repair. The product, named COAPTIUM Connect, is the result of a collaboration between 3D Systems and French medical technology company Tissium, combining advanced 3D printing techniques with programmable, biocompatible materials.
The implant offers a suture-free, atraumatic solution for reconnecting damaged peripheral nerves. Traditional nerve repair often requires stitches, which can increase trauma and healing time. In contrast, COAPTIUM Connect uses a photopolymer-based elastomeric material that is not only biocompatible and flexible but also fully bioresorbable, meaning the body can naturally break it down over time.
Continue reading… “3D-Printed, Bioresorbable Nerve Implants Gain FDA Approval in Breakthrough for Regenerative Medicine”
